/ CompletedNot Applicable 他达拉非片随机、开放、两制剂、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A formal bioequivalence study of tadalafil tablets in Chinese healthy subjects using a randomized, open-label, two-dose, crossover design
以杭州元素医药有限公司持证的他达拉非片为受试制剂;并以Eli Lilly Nederland B.V.的他达拉非片为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] The tadalafil tablets certified by Hangzhou Yuansu Pharmaceutical Co., Ltd. were used as the test preparation, and the tadalafil tablets of Eli Lilly Nederland B.V. were used as the reference preparation to evaluate the relative bioavailability and bioequivalence in humans.
/ CompletedNot Applicable 盐酸达泊西汀片随机、开放、单剂量、两制剂、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A formal bioequivalence trial of dapoxetine hydrochloride tablets in Chinese healthy subjects using a randomized, open-label, single-dose, two-dose, crossover design
主要目的:以杭州元素医药有限公司的盐酸达泊西汀片为受试制剂;并以Berlin-Chemie AG持证的盐酸达泊西汀片为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] Main purpose: To evaluate the relative bioavailability and bioequivalence in humans using dapoxetine hydrochloride tablets produced by Hangzhou Yuansu Pharmaceutical Co., Ltd. as the test preparation and dapoxetine hydrochloride tablets certified by Berlin-Chemie AG as the reference preparation.
100 Clinical Results associated with Hangzhou Element Medicine Co., Ltd.
0 Patents (Medical) associated with Hangzhou Element Medicine Co., Ltd.
100 Deals associated with Hangzhou Element Medicine Co., Ltd.
100 Translational Medicine associated with Hangzhou Element Medicine Co., Ltd.